These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 35226249)

  • 1. The relationship between central sensitization and disease activity, quality of life, and sleep quality among patients with axial spondyloarthritis.
    Aykurt Karlıbel I; Kasapoğlu Aksoy M
    Ir J Med Sci; 2023 Feb; 192(1):481-489. PubMed ID: 35226249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biopsychosocial factors should be considered when evaluating central sensitization in axial spondyloarthritis.
    Sariyildiz A; Coskun Benlidayi I; Turk I; Zengin Acemoglu SS; Unal I
    Rheumatol Int; 2023 May; 43(5):923-932. PubMed ID: 36966430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central sensitization has major impact on quality of life in patients with axial spondyloarthritis.
    Kieskamp SC; Paap D; Carbo MJG; Wink F; Bos R; Bootsma H; Arends S; Spoorenberg A
    Semin Arthritis Rheum; 2022 Feb; 52():151933. PubMed ID: 35033996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between psychiatric status, self-reported outcome measures, and clinical parameters in axial spondyloarthritis.
    Kilic G; Kilic E; Ozgocmen S
    Medicine (Baltimore); 2014 Dec; 93(29):e337. PubMed ID: 25546683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validity and reliability of the Ankylosing Spondylitis Disease Activity Score with C-reactive protein (ASDAS-CRP) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in patients with axial spondyloarthritis (axSpA) in Singapore.
    Kwan YH; Tan JJ; Phang JK; Fong W; Lim KK; Koh HL; Lui NL; Tan CS; Østbye T; Thumboo J; Leung YY
    Int J Rheum Dis; 2019 Dec; 22(12):2206-2212. PubMed ID: 31721427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posture, balance and gait in axial spondyloarthritis: a case-control study.
    Türk E; Yurdakul FG; Güler T; Bodur H
    Rheumatol Int; 2024 Nov; 44(11):2527-2538. PubMed ID: 39230687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the clinical characteristics and quality of life of male and female patients with non-radiographic axial spondyloarthritis.
    Unal Enginar A
    Int Immunopharmacol; 2023 Oct; 123():110627. PubMed ID: 37494835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discriminant validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis: a cohort study.
    Kilic E; Kilic G; Akgul O; Ozgocmen S
    Rheumatol Int; 2015 Jun; 35(6):981-9. PubMed ID: 25366469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construct validity of Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Ankylosing Spondylitis Disease Activity Score (ASDAS) treatment target cut-offs in a BASDAI treat-to-target axial spondyloarthritis cohort: a cross-sectional study.
    Michielsens C; Bolhuis TE; van Gaalen FA; van den Hoogen F; Verhoef LM; den Broeder N; den Broeder AA
    Scand J Rheumatol; 2024 May; 53(3):180-187. PubMed ID: 37339375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there any gender-specific difference in the cut-off values of ankylosing spondylitis disease activity score in patients with axial spondyloarthritis?
    Kilic G; Kilic E; Ozgocmen S
    Int J Rheum Dis; 2017 Sep; 20(9):1201-1211. PubMed ID: 27309497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis).
    Kroon FP; van der Burg LR; Ramiro S; Landewé RB; Buchbinder R; Falzon L; van der Heijde D
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD010952. PubMed ID: 26186173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic Pain and Assessment of Pain Sensitivity in Patients With Axial Spondyloarthritis: Results From the SPARTAKUS Cohort.
    Mogard E; Olofsson T; Bergman S; Bremander A; Kristensen LE; Olsen JK; Wallman JK; Lindqvist E
    J Rheumatol; 2021 Nov; 48(11):1672-1679. PubMed ID: 33323532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of ankylosing spondylitis and non-radiographic axial spondyloarthritis in a multi-ethnic Asian population of Singapore.
    Hong C; Kwan YH; Leung YY; Lui NL; Fong W
    Int J Rheum Dis; 2019 Aug; 22(8):1506-1511. PubMed ID: 31090201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Where we are in treat to target era? Predictive factors for remission and drug switching in patients with axial spondyloarthritis: a real-life evidence from BioStaR nationwide registry.
    Bodur H; Yurdakul FG; Ataman S; Cay HF; Gurer G; Capkin E; Sezer İ; Duruoz MT; Melikoglu MA; Rezvani A; Yagci I; Gogus F; Kamanli A; Akgul O; Cevik R
    Clin Rheumatol; 2022 Jul; 41(7):2053-2063. PubMed ID: 35353263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced sleep quality is highly prevalent and associated with physical function and cardiorespiratory fitness in patients with axial spondyloarthritis: a cross-sectional study.
    Fongen C; Dagfinrud H; Bilberg A; Sveaas SH
    Scand J Rheumatol; 2024 Mar; 53(2):130-139. PubMed ID: 38095452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procollagen I N-terminal peptide correlates with inflammation on sacroiliac joint magnetic resonance imaging in ankylosing spondylitis but not in non-radiographic axial spondyloarthritis: A cross-sectional study.
    Li X; Liang A; Chen Y; Lam NS; Long X; Xu X; Zhong S
    Mod Rheumatol; 2022 Jul; 32(4):770-775. PubMed ID: 34897520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients' Perspectives on Axial Pain in Relation to Inflammation and Structural Damage in a Large Cohort of Axial Spondyloarthritis Patients.
    Kampman A; Wink F; Paap D; Carbo M; Siderius M; Kieskamp S; Maas F; Spoorenberg A; Arends S
    Arthritis Care Res (Hoboken); 2024 Mar; 76(3):350-358. PubMed ID: 37781730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Central Sensitization in Patients with Familial Mediterranean Fever, Axial Spondyloarthritis, and Both Diseases.
    Kaya MN; Kılıç Ö; Doğan A; Yılmaz S; Tecer D
    Cureus; 2023 Sep; 15(9):e45459. PubMed ID: 37731687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central sensitization, illness perception and obesity should be considered when interpreting disease activity in axial spondyloarthritis.
    Kieskamp SC; Paap D; Carbo MJG; Wink F; Bos R; Bootsma H; Arends S; Spoorenberg A
    Rheumatology (Oxford); 2021 Oct; 60(10):4476-4485. PubMed ID: 33492397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing symptoms, treatment patterns, and quality of life of ankylosing spondylitis and non-radiographic axial spondyloarthritis patients in the USA: findings from a patient and rheumatologist Survey.
    Hunter T; Sandoval D; Booth N; Holdsworth E; Deodhar A
    Clin Rheumatol; 2021 Aug; 40(8):3161-3167. PubMed ID: 33611647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.